Case. Case. Management of Pulmonary Embolism in the ICU

Similar documents
RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM. David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain

Epidemiology. Update on Pulmonary Embolism. Keys to PE Management 5/5/2014. Diagnosis. Risk stratification. Treatment

Massive and Submassive Pulmonary Embolism: 2017 Update and Future Directions

Venous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.

Management of Acute Pulmonary Embolism. Judith Hurdman Consultant Respiratory Physician

Epidemiology: Incidence VTE: Mortality Morbidity Risk Factors: Acute Chronic : Genetic

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting

What is New in Acute Pulmonary Embolism? Interventional Treatment. Prof. Nils Kucher University Hospital Bern Switzerland

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS.

Disclosures. Objectives

Acute Management of Pulmonary Embolism

VTE & Medical Patients: Case Scenario

Is Thrombolysis Only for a Crisis?

Acute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT

Pulmonary Embolectomy:

Management of Pulmonary Embolism. Michael Hooper, M.D., MSc Associate Professor, Pulmonary and Critical Care Medicine Eastern Virginia Medical School

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS.

Acute and long-term treatment of VTE. Cecilia Becattini University of Perugia

Catheter Directed Interventions for Pulmonary Embolism

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

Management of sub-massive and massive pulmonary embolism:

DECLARATION OF CONFLICT OF INTEREST

Critical Review Form Therapy

Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD

Epidemiology of Pulmonary Embolism (PE)

Management of Intermediate-Risk Pulmonary Embolism

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

ORIGINAL INVESTIGATION. Thrombolysis vs Heparin in the Treatment of Pulmonary Embolism

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

Interventional Management of Acute Pulmonary Embolism

The OPTALYSE PE Trial Reducing thrombolytic dose and treatment times with EKOS in the treatment of pulmonary embolism patients

Surgical Thrombectomy for PE: Is it Making a Comeback

PE Pathway. The charts are listed as follows:

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital

The spectrum of clinical outcome of PE

Management of Massive and Sub-Massive Pulmonary Embolism

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

Single-Center, Retrospective, Observational Analysis of Patients with Submassive Pulmonary Embolism (PE) Receiving Catheter- Directed Thrombolysis

Updates in Management of Pulmonary Embolism (PE) David Ming, MD Duke Hospital Medicine July 24, 2017 Hilton Head, SC

Diagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go?

Τί κάνουμε όταν πάσχει η δεξιά κοιλία Οξεία πνευμονική εμβολή. Βασίλειος Σαχπεκίδης Επιμελητής Α Καρδιολογίας Γ.Ν.Θ. Παπαγεωργίου

Pulmonary embolism. Paweł Balsam

Mark H. Meissner, MD Peter Gloviczki Professor of Venous & Lymphatic Disorders University of Washington School of Medicine

Pulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy

How and Why to Form a PERT, Pulmonary Embolism Response Team

October 2017 Pulmonary Embolism

Ryan Walsh, MD Department of Emergency Medicine Madigan Army Medical Center

Year in Review 2014: Critical Care Medicine

PULMONARY EMBOLISM AND PERT. Jonathon Kirkland, DO OSU Department Chair, Radiology Head of Interventional Radiology

Heart Health ESC Guidelines on the diagnosis and management of acute pulmonary embolism

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Pulmonary embolism. Paweł Balsam MD, PhD

Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism Perlroth D J, Sanders G D, Gould M K

Severe pulmonary embolism: Catheter-based thrombolysis and medical treatment

8/16/2012. Pulmonary Embolism

4/18/2018. Objectives. Background. 1) Compare and contrast the various validated tools for the identification of patients with pulmonary embolism

Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

SESSION 4 12:45 2:15 PM

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS

Local and systemic thrombolytic therapy for acute venous thromboembolism

Acute and long-term treatment of PE. Cecilia Becattini University of Perugia

Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism. Rajat Deo, MD, MTR

Intraoperative Pulmonary Embolus

Catheter-directed Thrombolysis for Pulmonary Embolism

Practical Echocardiography and Ultrasound in Critical Care

Risk-Based Evaluation and Management of VTE

A Diagnostic Dilemma saved by sound

Pulmonary Thromboembolism

National Institute for Health and Care Excellence

You Won t Believe What I Saw on. Disclosures. Goals. Dimensions 2013 October 18 th Michael Pfeiffer, MD. No Financial Disclosures

Guideline for Thrombolysis Therapy in Pulmonary Embolism

Systemic or local thrombolysis in high-risk pulmonary embolism

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS

Challenges in Anticoagulation and Thromboembolism

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

ΠΝΔΤΜΟΝΙΚΗ ΔΜΒΟΛΗ Ο ΡΟΛΟ ΣΗ ΓΔΞΙΑ ΚΟΙΛΙΑ

Challenges in Anticoagulation Bridging and Emerging Therapies. Disclosures and Relationships. Objectives. Dr. Cumbler has no conflicts of interest

Emergency Pulmonary Embolectomy after Failed Thrombolysis in a Community Hospital: A Choice of Institutional Preference?

Optimal Management of Intermediate-Risk Pulmonary Embolism

Bilateral Central Pulmonary Embolism and Recent History of Ischemic Stroke

4/24/2017 CATHETER-DIRECTED THERAPIES FOR ACUTE PE THE GREY AREA OF SUBMASSIVE PE DISCLOSURES OBJECTIVES: INTRAVASCULAR LYTIC THERAPY

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS

Pulmonary and Critical Care Year in Review

National Institute for Health and Care Excellence

6 th Annual Scientific Sessions Georgia Vascular Society Reynolds Plantation, Lake Oconee 9/15/2018

The Evidence Base for Treating Acute DVT

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism

Pulmonary Embolism. current concepts. Dr Nick Taylor Visiting Emergency Specialist Teaching Hospital Karapitiya

REVIEW ON PULMONARY EMBOLISM

National Institute for Health and Care Excellence

Severe pulmonary embolism: surgical aspects. Oliver Reuthebuch Clinic for Cardiac Surgery University Hospital Basel Switzerland

A 50-year-old woman with syncope

Recent advances in the management of pulmonary embolism. Kodati Rakesh SR Pulmonary medicine

Plasma MR-proADM is superior to NTproBNP for all-cause short term mortality prediction in acute pulmonary embolism.

Use of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group

Thrombolysis for submassive pulmonary embolus

Should thrombolysis have a greater role in the management of pulmonary embolism?

Transcription:

Management of Pulmonary Embolism in the ICU Todd M Bull, M.D. Associate Professor of Medicine Division of Pulmonary Sciences and Critical Care Medicine Pulmonary Hypertension Center University of Colorado Health Sciences Center Case 32 year old women presents with sudden onset chest pain and SOB. 7 weeks post partum: C-section Vitals: p-140, BP 70/50, T-37, r-26, 92% 4 lpm Moderate respiratory distress Tachy, Loud P2, II/VI SEM CT PE study: Large saddle PE (rpa) Echo: Mod RV dilatation/hypokinesis RVSP 45 mmhg BNP-210, TNi- 2.4 Case IVF bolus and norepinephrine (1 ug/kg/min) is started. The patient s BP improves to 90/60 mmhg and she remains tachycardic (130 BPM). She has been started on UFheparin At this point you should a) Continue heparin and watch her closely b) Start front loaded TPA (10 mg over 10 minutes, then 90 mg over 2 hours) c) Place an IVC filter. d) Consult CV surgery for surgical embolectomy.

Outline Thrombolysis IVC Filters Emboelctomy Pulmonary Embolism Goldhaber, S. NEJM;339 1998 PE and the Right Ventricle Pulmonary Embolism: As goes your RV, so go you. Assessment of the RV is useful in prognostication Echo BNP Troponin

Echocardiography in P.E.: Role as prognostic indicator: Goldhaber SZ. Circulation 1997; 96: RV hypokinesis was associated with a doubling in mortality at 14 days. Ribeiro A. Am Heart J 1997; 134: RV hypokinesis was associated with tripling of mortality at 1 year. Kasper W. Pulmonary Embolism Registry (MAPPET). Heart 1997; 30: 1001 patients with P.E. and RV dysfunction. Increased mortality with worsening RV function. RV: pressure, time, volume Pressure Pressure Pressure Volume Volume Volume Clinical Indicators of Outcome Hypotension: Best indicator of mortality. All cause 3 month mortality is 58% if SBP < 90 vs. 15% in normal SBP RV dysfunction: Echo, BNP, Tni PESI score: (PE severity Index)

Thrombolytics Efficacy: UPET- 1970, 160 patients with PE, UK vs. Heparin. Improved hemodynamics and VQ at 24 hours. No difference between groups at 5 days. 8 other similar trials using various agents (SK, rt-pa) with same findings. Jerjes-Sanchez et al- 1995 8 patients with shock due to PE 4 who received SK lived, 4 who received heparin died. Trial stopped early Thrombolytics and RV dysfunction RV dysfunction: known marker mortality in PE Target this population RV dysfunction Pulmonary Hypertension Thrombolytic Therapy in Hemodynamically Stable P.E.: Multi center RCT n=256 patients Primary endpoint: 1) In hospital therapy 2) Escalation of therapy Konstantinides et al NEJM 2002

Konstantinides et al NEJM 2002 Thrombolysis Contraindications: Absolute *** CNS neoplasm History of hemorrhagic CVA Recent (< 2 months) CNS trauma or surgery Recent GIB (< 6 months) Relative Bleeding Diatheasis Uncontrolled severe HTN (SBP> 200, DPB>110 Surgery in past 10 days Thrombocytopenia (Plt < 100) Risks of Thrombolysis Risks of systemic thrombolysis 4.2% for major bleed 1.9% risk of CNS bleed Risk increases for secondary thrombolysis

IVC Filter IVC filters 400 patients randomized to filter or no filter (also LMWH) Primary outcome: VTE recurrence at day 12 and at 2 years Day 12: 1.1% vs. 4.8% recurrent PE 2 years: 20.8% vs. 11.6% DVT No difference in morality or bleeding at either time point IVC Filter 396/400 patients followed over 8 years PE in 6.2% (filter) vs. 15.1% (non-filter) p=0.008 DVT in 35.7% (filter) vs. 27% (non-filter) p=0.04 Postthrombotic syndrome 70% vs. 69% At 8 years 50% of patients had died in both groups

IVC Filter 1. Failure of adequate anticoagulation 2. Contraindication of anticoagulation 3. The next one will KILL you (pulmonary hypertension) IVC filter does not decrease two year risk of PE May decrease 8 year risk of PE Associated with increase in DVT for those with initial PE **Not controlled for use of anticoagulation Surgical Embolectomy A paucity of clinical trials Selection bias Previously only considered as option of last resort. Role of embolectomy Show the trend in mortality improvement 1968-1989: 35% 1990-1999: 30% 2000-2008: 19.1% 6% mortality reported by some groups No definitive study showing thrombolysis improves survival Some advocate surgical intervention in less critically ill patients.

Surgical Embolectomy Indications: Sub massive to Massive PE with RV dysfunction. Contraindication to thrombolysis Failure of thrombolysis PFO or ASD with right to left shunting RA or RV clot (thrombolysis an option here) Conclusions Thrombolysis cardiogenic shock RV dysfunction? IVC filter Lack adequate studies for most clinical scenarios Contraindication of anticoagulation failure of anticoagulation the next one is fatal Surgical Embolectomy Mortality improving? Consider it earlier (???) Case At this point you should a) Continue heparin and watch her closely b) Start front loaded TPA (10 mg over 10 minutes, then 90 mg over 2 hours) c) Place an IVC filter. d) Consult CV surgery for surgical embolectomy.

Case At this point you should a) Continue heparin and watch her closely b) Start front loaded TPA (10 mg over 10 minutes, then 90 mg over 2 hours) c) Place an IVC filter. d) Consult CV surgery for surgical embolectomy.